Global warming caused by climate change could exacerbate the burden of inpatient mortality from respiratory diseases during the warm season.
TG licenses Precision’s cell therapy; Innovent’s PhIII weight loss win; Atea’s positive hep C data
Plus news about Elicio Therapeutics, Boehringer Ingelheim, Chiesi, Oak Hill Bio and Zealand Pharma: TG Therapeutics licensed Precision BioSciences’ cell therapy for autoimmune diseases: TG will